Fernando Goni
12Patents
3h-index
4Co-inventors
49Inventor score
Filing activity: May 20, 2004 → Mar 22, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8409584B2 | Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins | Chemistry; Metallurgy | 9 | Active |
| US8685718B2 | Mucosal immunization to prevent prion infection | Human Necessities | 5 | Expired |
| US9834582B2 | Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins | Chemistry; Metallurgy | 3 | Active |
| US8906382B2 | Method for treating amyloid disease | Human Necessities | 3 | Active |
| US8951519B2 | Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins | Chemistry; Metallurgy | 2 | Active |
| US9770496B2 | Method for treating amyloid disease | Human Necessities | 0 | Active |
| US9295719B2 | Method for treating amyloid disease | Human Necessities | 0 | Active |
| US9700607B2 | Mucosal immunization to prevent prion infection | Human Necessities | 0 | Active |
| US9926353B2 | Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides | Physics | 0 | Active |
| US11332506B2 | Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides | Physics | 0 | Active |
| US10870709B2 | Specific murine and humanized monoclonal antibodies detecting pathology associated secondary structure changes in proteins and peptides | Chemistry; Metallurgy | 0 | Active |
| US10253070B2 | Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.